Skip to main content

NFL Gear Yields Little for Cancer

Only a small proportion of money made from breast cancer-themed football merchandise actually supports efforts to combat the disease.  

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

FLICKR, MARIANNE O'LEARThe perennial explosion of pink has hit the National Football League (NFL) again this month as part of its campaign to raise funds for the American Cancer Society (ACS). All proceeds from sales of breast cancer-themed merchandise go to the Society's Community Health Advocates National Grants for Empowerment (CHANGE) program, which aims to get more women screened for breast cancer. But “proceeds” actually turns out to be a “shockingly small” slice of the revenue pie from pink NFL merchandise, according to an analysis.

Business Insider reports that $11.25 out of every $100 earned from the gear goes to the cancer nonprofit. The majority of the remaining income goes to retailers, many of which are NFL teams, and manufacturers. Then there are the administrative costs of the ACS, too. “In the end, after everybody has taken their cut, only 8.01 percent of money spent on pink NFL merchandise is actually going towards cancer research,” according to Business Insider.

It's hard to argue that the NFL’s campaign doesn't bring awareness to breast cancer. But some have criticized the league as using the disease to merely market its brand to new fans—a practice that has come to be known as “pinkwashing.” Earlier this month, Ryan Basen wrote at Sports on Earth ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo